C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2001
10/18/2001	WO2001048242A9 Methods for amplifying and detecting multiple polynucleotides on a solid phase support
10/18/2001	WO2001040458A3 Preparation of sequence libraries from non-denatured rna and kits therefor
10/18/2001	WO2001038548A3 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
10/18/2001	WO2001036626A3 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
10/18/2001	WO2001034847A3 Flow cell for synthesis of arrays of dna probes and the like
10/18/2001	WO2001032832A3 Antisense inhibition of nucleolin expression
10/18/2001	WO2001031015A3 36p6d5: secreted tumor antigen
10/18/2001	WO2001029210B1 A method for establishing connections between genes
10/18/2001	WO2001027613A3 Improved method for the detection of acid resistant microorganisms in a stool
10/18/2001	WO2001027315A3 For substances acting on msk1 or msk2
10/18/2001	WO2001027241B1 Method of introducing a plurality of genes into plants
10/18/2001	WO2001026608A3 Dna vaccines encoding antigen linked to a domain that binds cd40
10/18/2001	WO2001025451A3 Cloning vectors
10/18/2001	WO2001025435A3 In vivo treatment of joint disease using interleukin-1 receptor antagonists
10/18/2001	WO2001025430A3 Novel human membrane proteins
10/18/2001	WO2001023540A3 P-glycoproteins and uses thereof
10/18/2001	WO2001023525A3 Methods of producing cloned and transgenic mammals
10/18/2001	WO2001023411A3 Incorporation of modified nucleotides by archaeon dna polymerases and related methods
10/18/2001	WO2001022090A9 Method for identifying compounds useful in the therapy of bone disorders
10/18/2001	WO2001021825A3 Novel enzymes which dehydrate glycerol
10/18/2001	WO2001021809A3 Stachybotrys phenol oxidizing enzyme
10/18/2001	WO2001021783A3 Seed-preferred promoter from maize
10/18/2001	WO2001021780A3 Targeted gene removal
10/18/2001	WO2001021201A3 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen
10/18/2001	WO2001021199B1 Highly efficient dendritic cell-targeted dna-vaccination
10/18/2001	WO2001020336A3 SCREENING FOR α2δ-1 SUBUNIT BINDING LIGANDS
10/18/2001	WO2001020012A3 Enhanced plant cell transformation by addition of host genes involved in t-dna integration
10/18/2001	WO2001020004A3 Protein phosphatase and kinase proteins
10/18/2001	WO2001016144A3 Plant derived calcium-dependent calmodulin-binding polypeptides and polynucleotides encoding same
10/18/2001	WO2001012803A3 Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus
10/18/2001	WO2001005971A9 Secreted polypeptides and corresponding polynucleotides
10/18/2001	WO2001000802A3 Partial sequences of the genes of the primary and secondary metabolism from corynebacterium glutamicum
10/18/2001	WO2000073460A3 Modified cytokine for its stabilisation
10/18/2001	WO2000057837A9 Compositions and methods for effecting the levels of cholesterol
10/18/2001	WO2000055361A3 Method for identifying organisms by means of comparative genetic analysis and primers and hybridisation probes for carrying out this method
10/18/2001	WO2000046394A9 Tryptophan synthase as a site of herbicide action
10/18/2001	WO2000046236A9 Novel rgs-containing molecules and uses thereof
10/18/2001	WO2000044893A9 In vitro activated gamma delta lymphocytes
10/18/2001	WO2000044782A9 Ewing's tumour antigen, nucleic acid and antibodies
10/18/2001	WO2000043498A9 Human liver progenitors
10/18/2001	WO2000039301A9 Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
10/18/2001	WO2000039283A9 Use of cd40 engagement to alter t cell receptor usage
10/18/2001	WO2000037635A3 Genetic suppressor elements against human immunodeficiency virus
10/18/2001	WO2000032233A3 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/18/2001	US20010032344 Fertile transgenic corn plants
10/18/2001	US20010032342 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase for improvement and optimization of plant phenotypes
10/18/2001	US20010032341 Modification of the expression of UDP-glucose 4-epimerase may result in grains with reduced fiber and increased levels of starch thus adding value for feed, food, and industrial applications of crops
10/18/2001	US20010032340 Controlling offspring's sex ratio by targeting transgenes onto the sex chromosomes
10/18/2001	US20010032339 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
10/18/2001	US20010032338 Screening method for PPAR-gamma ligands
10/18/2001	US20010032337 Introduction of exogenous nucleotide sequences into a genome by microinjection of infectious retrovirus into the perivitelline space of the egg; making a bovine embryo; use to confer disease resistance, for example
10/18/2001	US20010032052 Apparatus and method for automated protein design
10/18/2001	US20010031859 Human cell line characterized by expression of code sequence for antiapoptotic protein and level of cytokine production twice that of of cytokine production exhibited by parental cell line that does not express code for antiapoptotic protein
10/18/2001	US20010031856 Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
10/18/2001	US20010031740 Mixture containing organic halide
10/18/2001	US20010031724 Dominant selectable marker for gene transformation and disruption in yeasts
10/18/2001	US20010031722 Methods and reagents for facilitating transcription
10/18/2001	US20010031499 Used to transform cells such as erythrocytes to deliver therapeutic and/or imaging agents to a mammal; comprising amodule for loading agent into cell and module for sensitizing cell to release agent upon exposure to energy field
10/18/2001	US20010031498 Treating polyamine with functionalized hemiacetal in presence of titanium isopropoxide and sodium borohydride; synthetic genetic vector
10/18/2001	US20010031489 Synthesis and isolation of polylactone polyester biopolymers from recombinant bacteria comprising fragment of poly (hydroxy fatty acid) synthase from Thiocapsa incubated with carbon source
10/18/2001	US20010031486 Modification of enzyme by substitution with non-native amino acids to reduce inhibition by purine nucleotide end products
10/18/2001	US20010031485 Nucleic acid coding for fusion protein which binds receptor; internalized by endocytosis; inhibits ribosomes and angiogenesis; therapy for tumors, metastasis, eye disorders, chronic inflammation and ischemic injuries
10/18/2001	US20010031483 Synthesizing polynucleotides employing releasable primers with specific releasing enzymes
10/18/2001	US20010031476 Determining rate of bone resorption by measuring peptides in body fluid having 3-hydroxypyridinium cross-link; diagnostic tool for Paget's disease
10/18/2001	US20010031474 Chimeric neuropeptide Y receptors
10/18/2001	US20010031473 Aqueous solution comprising: lipid, enzyme to degrade cell structure, non-ionic membrane fluidizing compound, and metal chelator; nondenaturing and non-inhibitory of enzymes or proteins; amplification; labeling; detection
10/18/2001	US20010031472 Moiety of at least two analyte residues linked to reporter group detectable by mass spectrometry for analysis of proteins/peptides, nucleic acids/oligonucleotides, carbohydrates etc.
10/18/2001	US20010031470 Using the depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of a predetermined nucleic acid; detection of single nucleotide polymorphisms, speciation, viral load, genotyping
10/18/2001	US20010031466 Contacting target RNA sequences with library of random oligonucleotides and a hydrolytic agent such that a subgroup of the oligonucleotides hybridizes to the target RNA which is hydrolyzed near the 5' end; templates for primer extension
10/18/2001	US20010031465 Isolated nucleic acid encoding a lamin B receptor/sterol reductase of given sequence; use to manipulate cell cycle regulation and in plant or eukaryotic cell transformability
10/18/2001	US20010031464 Multihued labels
10/18/2001	US20010031461 Potentiating a cell for sensitivity to a heterologous polynucleotide; host cells can be immediately used in further experiments to determine the function of a heterologous gene, and for drug screening
10/18/2001	US20010031267 Method for treatment of canine distemper
10/18/2001	US20010031261 Use of genetically engineered antibodies to treat multiple myeloma
10/18/2001	US20010029794 System and method for filling a substrate with a liquid sample
10/18/2001	DE10016881A1 Gezielte Transfektion von Zellen mittels biotinyliertem Dendrimer Targeted transfection of cells using biotinylated dendrimer
10/18/2001	DE10016877A1 (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung (Glyco) proteins with high immunoreactivity, and a method for their preparation
10/18/2001	DE10016083A1 Nicht-menschliches Tiermodell für Wachstumsdefizienz und Defekte der Informationsverarbeitung oder der kognitiven Funktion und seine Verwendung A non-human animal model for Wachstumsdefizienz and defects of the information processing or the cognitive function and its use
10/18/2001	DE10015906A1 Directed gene transfer to eukaryotic cells, useful for antisense inhibition of specific genes, comprises using a complex of polyethyleneimine, nucleic acid and monoclonal antibodies
10/18/2001	DE10015818A1 Biosensor und Verfahren zum Ermitteln makromolekularer Biopolymere mit einem Biosensor Biosensor and method for determining macromolecular biopolymers with a biosensor
10/18/2001	DE10015816A1 Biosensorchip Biosensor chip
10/18/2001	DE10014638A1 Chitinase cDNSen für eine Niedertemperatur-Expression sowie Verfahren zu deren Isolierung Chitinase cDNSen for a low-temperature expression as well as methods for their isolation
10/18/2001	DE10007234A1 Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems Peptide and nucleic acid coding for determining diagnosis and treatment of diseases of the nervous system
10/18/2001	CA2789254A1 Signal transduction stress-related proteins and methods of use in plants
10/18/2001	CA2785943A1 Protein kinase stress-related proteins and methods of use in plants
10/18/2001	CA2767275A1 Cell cycle stress-related proteins and methods of use in plants
10/18/2001	CA2767239A1 Transcription factor stress-related proteins and methods of use in plants
10/18/2001	CA2659656A1 The use of vegf165 to treat neuron disorders
10/18/2001	CA2654413A1 Use of vegf and homologues to treat neuron disorders
10/18/2001	CA2416118A1 Method for identifying and isolating genome fragments with linkage disequilibrium
10/18/2001	CA2414652A1 Animal and cell models for type ii diabetes and their use
10/18/2001	CA2406485A1 Hpv-specific short-mers
10/18/2001	CA2406448A1 Identification of a human gaba transporter
10/18/2001	CA2406370A1 Gpcr-proteins and nucleic acids encoding same
10/18/2001	CA2406366A1 Muir-torre-like syndrome infhit deficient mice
10/18/2001	CA2406352A1 Peptide conjugates for drug delivery
10/18/2001	CA2406233A1 Compositions for drug delivery
10/18/2001	CA2406058A1 Tm4sf receptor polynucleotides, polypeptides, and antibodies
10/18/2001	CA2406033A1 Anti-d monoclonal antibodies
10/18/2001	CA2405912A1 Albumin fusion proteins

1 ... 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 2979 2980 ... 4023